Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

Improving clinical outcomes among high risk Class III β thalassemia major patients (Class IIIHR) receiving an allogeneic SCT remains a challenge. From October, 2009 a treosulfan based regimen (TreoFluT) was used for all consecutive Class III patients (n = 50). The clinical outcomes were compared wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathews, Vikram, George, Biju, Viswabandya, Auro, Abraham, Aby, Ahmed, Rayaz, Ganapule, Abhijeet, Sindhuvi, Eunice, Lakshmi, Kavitha M., Srivastava, Alok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637210/
https://www.ncbi.nlm.nih.gov/pubmed/23637873
http://dx.doi.org/10.1371/journal.pone.0061637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637210/
https://www.ncbi.nlm.nih.gov/pubmed/23637873
http://dx.doi.org/10.1371/journal.pone.0061637

Ejemplares similares